Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
Haemophilia ; 24(4): e187-e193, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29873151

ABSTRACT

INTRODUCTION: Haemophilia is one of the most common inherited bleeding disorders in the Emergency Department (ED). The most dangerous site of bleeding is the central nervous system. AIMS: To describe the characteristics of haemophiliacs arrived to our ED following a head trauma and to analyse the incidence of intracranial haemorrhage (ICH). MATERIALS AND METHODS: Retrospective, analytical, observational study, conducted in a Paediatric ED. We included haemophilic patients aged from birth to 16 years who consulted after a head trauma over a 6-year period. Data collected included age, type of haemophilia and head trauma, symptoms, prophylaxis status, CT imaging, treatment and number of visits to the ED. RESULTS: About 46 males and 85 episodes were analysed. The median age was 2.38 years. Severe haemophilia A was the most frequent type of disease (50%). All head injuries were mild, and the most frequent mechanism was a collision with an object (38.8%). In 62 episodes (72.9%) the patients were asymptomatic. The rest 23 events had symptomatology, being the most common headache (26%), emesis (21.7%) and drowsiness (17.4%). Head CT was obtained in 31 episodes, founding altered results in 10 (6 of them corresponding to ICH). All the patients with ICH had symptomatology. About 37 episodes required admission. CONCLUSION: Intracranial haemorrhage is one of the most dangerous events in haemophiliacs and it may occur after a head trauma. Our study suggests that, in case of head trauma, CT must be obtained in symptomatic patients and in those with additional risk factors. Asymptomatic patients must have prolonged observation.


Subject(s)
Craniocerebral Trauma/complications , Emergency Service, Hospital , Hemophilia A/complications , Adolescent , Child , Child, Preschool , Craniocerebral Trauma/diagnosis , Craniocerebral Trauma/therapy , Female , Humans , Male , Risk Factors , Tertiary Healthcare
3.
Thromb Haemost ; 112(1): 65-72, 2014 Jul 03.
Article in English | MEDLINE | ID: mdl-24500066

ABSTRACT

Thrombopoietin receptor agonists (TPO-RA) have recently been introduced for the treatment of immune thrombocytopenia (ITP), an anti-platelet-antibodies autoimmune disease. The observation of a low frequency of bleeding episodes despite their thrombocytopenia suggests the existence of a compensatory mechanism. This study aimed to evaluate the effect of TPO-RA treatment on platelet function and on the procoagulant state in ITP patients before (ITP-bR) and after responding (ITP-aR) to treatment. Plasma- and microparticle (MP)-associated procoagulant capacity from ITP patients was similar before and after responding to the TPO-RA regimen but higher than the healthy control values. High MP-associated procoagulant activity did not seem to be due to increased platelet activation, since platelet stimulation by agonists was reduced in ITP-bR and ITP-aR patients. It could be related to increased platelet apoptosis, evaluated in terms of surface phosphatidylserine (PS), observed in both ITP groups. In summary, TPO-RA treatment increased platelet count but did not ameliorate their function and did not change plasma- and MP-associated procoagulant state of ITP patient responders to this therapy.


Subject(s)
Benzoates/administration & dosage , Blood Coagulation , Blood Platelets/drug effects , Hydrazines/administration & dosage , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Pyrazoles/administration & dosage , Receptors, Fc/administration & dosage , Recombinant Fusion Proteins/administration & dosage , Thrombopoietin/administration & dosage , Adult , Aged , Apoptosis/drug effects , Autoantibodies/metabolism , Benzoates/adverse effects , Blood Coagulation/drug effects , Blood Platelets/immunology , Cell-Derived Microparticles/metabolism , Female , Humans , Hydrazines/adverse effects , Male , Middle Aged , Plasma/metabolism , Platelet Activation/drug effects , Prospective Studies , Pyrazoles/adverse effects , Receptors, Thrombopoietin/agonists , Recombinant Fusion Proteins/adverse effects , Thrombopoietin/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...